Ketocip Tablet contains Ketoconazole 200mg, an imidazole antifungal agent indicated for the treatment of various systemic and superficial fungal infections. Ketoconazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Ketocip is commonly prescribed for infections caused by dermatophytes, yeasts, and other susceptible fungi, including candidiasis, tinea corporis, tinea cruris, tinea pedis, and seborrheic dermatitis. It may also be used in certain systemic mycoses under medical supervision. The tablet formulation allows for convenient oral administration, ensuring adequate systemic absorption. Ketocip should be taken as directed by a healthcare professional, typically once or twice daily with food to enhance absorption and reduce gastrointestinal discomfort. Caution is advised in patients with hepatic impairment due to potential hepatotoxicity; liver function tests should be monitored during prolonged therapy. Ketocip is contraindicated in individuals with known hypersensitivity to ketoconazole or other azole antifungals. Potential drug interactions may occur due to ketoconazole’s inhibition of cytochrome P450 enzymes; therefore, concomitant use with certain medications should be avoided or closely monitored. Patients should complete the full prescribed course to prevent recurrence and resistance.